Načítá se...
Integrating genomic signatures for treatment selection with Bayesian predictive failure time models
Over the past decade, a tremendous amount of resources have been dedicated to the pursuit of developing genomic signatures that effectively match patients with targeted therapies. Although dozens of therapies that target DNA mutations have been developed, the practice of studying single candidate ge...
Uloženo v:
| Vydáno v: | Stat Methods Med Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463529/ https://ncbi.nlm.nih.gov/pubmed/27807177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0962280216675373 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|